Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction

NCT05393557 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT05393557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05393557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2024
Completion date
November 30, 2026
Enrollment
626 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

large thrombus burden, no-reflow phenomenon, stemi